Oramed Pharmaceuticals
ORMP
#9090
Rank
A$0.18 B
Marketcap
A$4.55
Share price
4.66%
Change (1 day)
17.88%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Cash on Hand

Cash on Hand as of June 2025 : A$0.14 Billion

According to Oramed Pharmaceuticals's latest financial reports the company has A$0.14 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oramed Pharmaceuticals - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.22 B-4.06%
2023-12-31A$0.23 B3.94%
2022-12-31A$0.22 B
2021-08-31A$0.12 B137.97%
2020-08-31A$54.05 M12.83%
2019-08-31A$47.9 M12.96%
2018-08-31A$42.41 M67.35%
2017-08-31A$25.34 M-38.55%
2016-08-31A$41.24 M70.19%
2015-08-31A$24.23 M6.2%
2014-08-31A$22.81 M139.69%
2013-08-31A$9.51 M92.64%
2012-08-31A$4.94 M178.33%
2011-08-31A$1.77 M32.21%
2010-08-31A$1.34 M-59.18%
2009-08-31A$3.28 M-44.13%
2008-08-31A$5.88 M151.24%
2007-08-31A$2.34 M920.6%
2006-08-31A$0.22 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ultragenyx Pharmaceutical
RARE
A$0.63 B 334.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$7.67 B 5,131.25%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
A$15.66 B 10,571.74%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
A$0.12 B-12.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
A$0.17 B 18.39%๐Ÿ‡บ๐Ÿ‡ธ USA